TOPIC: "The "Gaps" in Eczematous Dermatoses" and "Updating Valley Fever Serology: It's not World War II Anymore"
Speakers: Dr. Vivian Shi and Dr. John Galgiani
Dr. Vivian Shi:Dr. Shi has mentored residents, undergraduate and medical students on multiple clinical research studies. She has been the advisor of the Dermatology Student Interest Group. She is dedicated to community and global outreach for the underserved and has completed medical outreach trips to serve patients in remote areas of India, Burma, China and Vietnam. Dr. Shi has served as the investigator on multiple clinical studies. Her research interests include: Disease burden, Therapeutics and patient education for atopic dermatitis, Measuring skin barrier function and inflammation using noninvasive devices, Optimizing transepidermal drug delivery, Oxidative stress and anti-oxidants in eczematous skin diseases. Her current position at the UA consists of collaborations with the College of Optical Sciences to develop novel multi-modal techniques to detect and evaluate skin inflammation and barrier defects.
Dr. John Galgiani:John Galgiani joined the Division of Infectious Diseases, University of Arizona, College of Medicine, in 1978 after completing his Infectious Diseases Fellowship at Stanford University and his MD at Northwestern University. Since then he has increasingly moved from a general interest in medical mycology to a focus on coccidioidomycosis (San Joaquin Valley Fever). His research contributions in the areas of epidemiology, new treatments, pathogenesis, diagnostics, and preventative vaccines, have resulted in over 170 peer-reviewed publications. Since 1974, he has been a member of the Coccidioidomycosis Study Group, and for 21 years served as its secretary. For nearly 20 years, Dr. Galgiani was chair of the NIH-Mycoses Study Group Subproject on therapeutic trials in coccidioidomycosis. Since 2000, he has been the lead author on the Infectious Diseases Society of America’s coccidioidomycosis practice guidelines and its two subsequent updates. During the same period, Dr. Galgiani has authored the chapter on coccidioidomycosis for the textbook, Principles and Practice of Infectious Diseases. He has had nearly continuous research support from the Veterans Administration until 2009. Research funding has also come from the NIH, currently for studies of the immuno-genetics of human susceptibility to disseminated coccidioidal infection and the development of a vaccine to prevent Valley Fever in dogs and humans. In 1996, the Arizona Board of Regents approved Dr. Galgiani’s proposal to establish the Valley Fever Center for Excellence in order to establish an institutional commitment by the University of Arizona to address this endemic problem so important to the state.
The monthly series, which began in September 2016, runs through June with lectures held on the second Thursday of the month—same time, same location. A light lunch will be served in the style of Grand Rounds.
UAHS 5403 and Banner-UMC-SC 3030